---------- Weitergeleitete Nachricht ----------
Von: <scanner@biblionetgroningen.nl
Datum: Mittwoch, 30. September 2020
Betreff: Send data from MFP11649737 30/09/2020 17:35
An: RMGeilich@gmail.com
Scanned from MFP11649737
Date:30/09/2020 17:35
Pages:12
Resolution:200x200 DPI
------------------------------
6 Anhänge
· Drucken
· Drucken
· Drucken
· Drucken
· Drucken
· Drucken
| |||
| Antwort: DNS Error: 6542336 DNS type 'mx' lookup of bioregiostern.de responded with code NXDOMAIN Domain name not found: bioregiostern.de |
| |||
| Die Antwort vom Remoteserver ist: 552 5.3.4 Message size exceeds fixed limit |
An:
Datum:
Delivery has failed to these recipients or groups:
The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.
The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.
The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.
The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.
The email address you entered couldn't be found. Please check the recipient's email address and try to resend the message. If the problem continues, please contact your email admin.
Diagnostic information for administrators:
Generating server: FDSWV30901.fda.gov
CBERProductJurisdication@fda.
Remote Server returned '550 5.1.10 RESOLVER.ADR.
FDAImportInquiries@fda.hhs.gov
Remote Server returned '550 5.1.10 RESOLVER.ADR.
bp-deviations@fda.hhs.gov
Remote Server returned '550 5.1.10 RESOLVER.ADR.
cberspeakersliasion@fda.hhs.
Remote Server returned '550 5.1.10 RESOLVER.ADR.
dgod@fda.hhs.gov
Remote Server returned '550 5.1.10 RESOLVER.ADR.
hctp-deviations@fda.hhs.gov
Remote Server returned '550 5.1.10 RESOLVER.ADR.
Original message headers:
Received: from FDSWV09480.fda.gov (10.168.16.139) by FDSWV30901.fda.gov (10.185.43.41) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384_P256) id 15.1.2044.4; Sat, 3 Oct 2020 09:54:45 -0400 Received: from ironport6.fda.gov (10.168.18.7) by FDSWV09480.fda.gov (10.168.17.130) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_ 256_CBC_SHA384_P256) id 15.1.2044.4 via Frontend Transport; Sat, 3 Oct 2020 09:54:45 -0400 IronPort-SDR: Q7SIc6UXbIf18XlvYptrW84BGZXwAi rUcWW0PIRg+xrPN5Q06CFWb+ DMv53KBNrtT7jC+hSXTr oyjX4/ Y0vWYTfmGXq7Q3lVGAghmj800OI= X-SBRS: 5.2 X-MID: 46530355 Received: from ipss1-host175.is1e1.is. centurylink.net ([65.153.203.175]) by smtp6.fda.gov with ESMTP; 03 Oct 2020 09:54:38 -0400 Received: from smtp8.fda.gov (unknown [150.148.18.43]) by ipss1-host175.is1e1.is. centurylink.net (Postfix) with ESMTP id 239469980008; Sat, 3 Oct 2020 13:54:29 +0000 (GMT) Authentication-Results: smtp8.fda.gov; spf=None smtp.pra=rmgeilich@gmail.com; spf=Pass smtp.mailfrom=rmgeilich@gmail. com; spf=None smtp.helo=postmaster@mail-qk1- f195.google.com; dkim=pass (signature verified) header.i=@gmail.com; dmarc=pass (p=none dis=none) d=gmail.com IronPort-SDR: GxDYbiFuRX8GJcP8fYJdqDByqT5zOh ExQJ86fRWpOXnI1GmeJAnLcAuMBE/ jDkz1piec6Yteqm 2BbTGPPjytdQ6o1bQqZrmZr+ DPj1J8Uog= X-SBRS: 2.7 X-MID: 46435676 X-IronPort-AV: E=Sophos;i="5.77,331, 1596513600"; d="pdf'?jpg'145?scan'145,208, 145";a="46435676" X-Qwest-Attempt: Yes Received: from mail-qk1-f195.google.com ([209.85.222.195]) by smtp8.fda.gov with ESMTP/TLS/ECDHE-RSA-AES256- GCM-SHA384; 03 Oct 2020 09:54:26 -0400 Received: by mail-qk1-f195.google.com with SMTP id s7so603131qkh.11; Sat, 03 Oct 2020 06:54:25 -0700 (PDT) DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=20161025; h=mime-version:from:date: message-id:subject:to:cc; bh= ZVInl6H6p7XYrfmph13Dl1dw5l3xv0 YxgsukCcBfxDk=; b= udNFql1zlt4LI7CLNHRmTtA1NWAvvp ZGpK86OYO7qYk50DtLiSvX1mC3Y9Hy SHEbae EdjgK9SmwuYqprAGkQMszQUXzJ8r49 0+QH/r5dxLkfiwr4TA4k/ fPLBFphfZAHYAte6W cB4VIka+ Z163wJHAL4L4X61gTR3RploF9zWcej JKWkkSbSBrOynVHbDQNSs8lJ7nMfrj gP7BFmYEhlauFNQESRehsQMXSQpCek sBBWGVy2svbQVHgsv6ZjyHTPh5vW22 iEXSAC+F HNGvWDgXZo8gV2RKcebolACbOS/ nA2VQP02nwYlOMsUeYbVKuJpkCVO/ rqZAvnsbDjEK +alg== X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=x-gm-message-state:mime- version:from:date:message-id: subject:to:cc; bh= ZVInl6H6p7XYrfmph13Dl1dw5l3xv0 YxgsukCcBfxDk=; b=l5x+Nv0+Eks/ K8E857zxDygXW560OcTGx+ qYhC2z1USwUrKRWRe3ihQeqfXWeHo4 iA Pwaw/jQBwy9E/ 2UmcngzkkCW5r4lTOQMdk3b6KXy9f8 much1okxunfyC4U6naiC4cjBf 4aWIE33rfBFCVSHx2dqZuuKlnaMUte 0sX1UXoXqwYOewKRIk7nFO75HnZ0+ ktKPoUp6l ZVljBWaOSmIcREFVZTHqnEwsfW3kxc Nvh72N3pWb8pmvhnyMebJKfTuXgWzM U2kQgHKk THsWhOuVsBh4yxODOLUd/ ciRNayDCt+UOW+ vDV4BSlKWHrN3dQo5R1z5QYkWxbWEb a4g BWPQ== X-Gm-Message-State: AOAM532Tc1uC9x5wgkxQM+v2IU1/ 6ZUhWvk/1mnT9YKiL/JKjfE3pPMZ f22itcPAUSVJOUbdqZg1WVP9/ mjodoT7f0eHFmM= X-Google-Smtp-Source: ABdhPJx49ECSdZm7JTln4WS/O2/ qWOiGoKUdcHBrvOJFHekTMx2N3ne8N 5X1GL/MpY5pJ9WV4noNcCf/ FW1GWqHUy0g= X-Received: by 2002:a37:952:: with SMTP id 79mr6489658qkj.57. 1601733259116; Sat, 03 Oct 2020 06:54:19 -0700 (PDT) MIME-Version: 1.0 Received: by 2002:a0c:e502:0:0:0:0:0 with HTTP; Sat, 3 Oct 2020 06:54:18 -0700 (PDT) From: regina geilich <rmgeilich@gmail.com> Date: Sat, 3 Oct 2020 15:54:18 +0200 Message-ID: <CANhAu4sjDxcm17shXrp- 3UDNWABWb- NcA9hJnzB59AY8Nayiaw@mail. gmail.com> Subject: Open Letter vor F D A , Pei , EMA , Offices , vaccination companies and institutions To: <Pei@pei.de> CC: <info@biontech.de>, <Media@biontech.de>, <info@curevac.com>, <communications@curevac.com>, <office@prime-vector- technologies.com>, <schweickhardt@bioregiostern. de>, <info@vaers.org>, <info@baseclick.eu>, <admin@baseclick.eu>, <FDAImportInquiries@fda.hhs. gov>, <FDAOMA@fda.hhs.gov>, <CDRH-EUA-Templates@fda.hhs. gov>, <industry.biologics@fda.hhs. gov>, <ombuds@oc.fda.gov>, <dgod@fda.hhs.gov>, <CBERProductJurisdication@fda. hhs.gov>, <cberspeakersliasion@fda.hhs. gov>, <hctp-deviations@fda.hhs.gov>, <fatalities2@fda.hhs.gov>, <press@ema.europa.eu>, <certificate@ema.europa.eu>, <innovation@pei.de>, <ORAInfo@fda.hhs.gov>, <bp-deviations@fda.hhs.gov>, <info@baek.de>, <presse@baek.de>, <poststelle@bmbf-bund.de-mail. de> Content-Type: multipart/mixed; boundary=" 000000000000f0d12405b0c49506" X-Qwest-Proxy-Host: ipss1-host175.is1e1.is. centurylink.net X-Qwest-Process-Uuid: 52b3ac0d-2116-42f0-bb01- 8518d9d086fa-3013235783827587 X-Qwest-Status: hEUBLG9ErOsrnKeZ Return-Path: rmgeilich@gmail.com
Warum ist diese E-Mail im Spamordner? Diese Nachricht weist große Ähnlichkeiten mit anderen Nachrichten auf, die von unseren Spamfiltern als Spam eingestuft wurden.
Dear mailer,
Thank you for your submission.
Important: EudraLink account required
As of 30 March 2020, the Agency will no longer provide printed certificates but only electronically signed and authenticated certificates to maintain EMA's ability to provide these documents during the COVID-19 pandemic. Electronic certificates will be mailed to the recipient via our secure document mailing system EudraLink. You will need to have an EudraLink account in order to be able to receive certificates. If you do not have an EudraLink account yet, please request it via the EMA service desk. Please attach this email to the request
In order to access the EMA service desk and request access to EudraLink you will need to create an EMA account. Please follow the instruction under "Create a new EMA account" in this link: https://register.ema.europa.
Once the EMA account has been created and you have received your credentials you can request a EudraLink account in the following link: https://servicedesk.ema.
Thank you for your co-operation.
Yours sincerely,
Certificates Team
Procedures Office
Committees and Quality Assurance Department
Human Medicines Division
[3-EMA banner - option 1]<https://www.ema.europa.eu/
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Telephone +31 (0)88 781 6000
Certificate@ema.europa.eu | www.ema.europa.eu |
www.ema.europa.eu<https://www.
______________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
______________________________
Thank you for your submission.
Important: EudraLink account required
As of 30 March 2020, the Agency will no longer provide printed certificates but only electronically signed and authenticated certificates to maintain EMA's ability to provide these documents during the COVID-19 pandemic. Electronic certificates will be mailed to the recipient via our secure document mailing system EudraLink. You will need to have an EudraLink account in order to be able to receive certificates. If you do not have an EudraLink account yet, please request it via the EMA service desk. Please attach this email to the request
In order to access the EMA service desk and request access to EudraLink you will need to create an EMA account. Please follow the instruction under "Create a new EMA account" in this link: https://register.ema.europa.
Once the EMA account has been created and you have received your credentials you can request a EudraLink account in the following link: https://servicedesk.ema.
Thank you for your co-operation.
Yours sincerely,
Certificates Team
Procedures Office
Committees and Quality Assurance Department
Human Medicines Division
[3-EMA banner - option 1]<https://www.ema.europa.eu/
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Telephone +31 (0)88 781 6000
Certificate@ema.europa.eu | www.ema.europa.eu |
www.ema.europa.eu<https://www.
______________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
______________________________
· Drucken
No comments:
Post a Comment